First American Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$742K Buy
3,503
+31
+0.9% +$6.08K 0.04% 158
2026
Q1
$680K Buy
3,472
+89
+3% +$17.3K 0.04% 146
2025
Q4
$587K Buy
3,383
+90
+3% +$16.4K 0.04% 151
2025
Q3
$628K Buy
3,293
+130
+4% +$23.1K 0.04% 149
2025
Q2
$568K Buy
+3,163
New +$549K 0.04% 142

Other funds holding DGX

First American Bank's DGX Position: Q2 2026 in Review

First American Bank increased its Quest Diagnostics (DGX) stake by 0.89% in Q2 2026, buying an estimated $6.08K and bringing the position to 3,503 shares worth $742K. The position accounts for 0.04% of the portfolio, ranked #158.

First American Bank first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • First American Bank held 3,503 shares of Quest Diagnostics worth $742K as of Q2 2026.
  • First American Bank bought 31 Quest Diagnostics shares in Q2 2026, an estimated $6.08K.
  • Quest Diagnostics made up 0.04% of First American Bank's portfolio in Q2 2026, its #158 holding.
  • First American Bank first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.